Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hyster-Yale (HY) EBITDA (2016 - 2025)

Historic EBITDA for Hyster-Yale (HY) over the last 15 years, with Q3 2025 value amounting to $2.3 million.

  • Hyster-Yale's EBITDA fell 9305.14% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.4 million, marking a year-over-year decrease of 8185.3%. This contributed to the annual value of $244.8 million for FY2024, which is 1729.76% up from last year.
  • Hyster-Yale's EBITDA amounted to $2.3 million in Q3 2025, which was down 9305.14% from -$8.5 million recorded in Q2 2025.
  • Over the past 5 years, Hyster-Yale's EBITDA peaked at $95.6 million during Q2 2024, and registered a low of -$107.0 million during Q4 2021.
  • Moreover, its 5-year median value for EBITDA was $19.8 million (2022), whereas its average is $14.6 million.
  • In the last 5 years, Hyster-Yale's EBITDA plummeted by 88102.19% in 2021 and then surged by 47452.23% in 2023.
  • Hyster-Yale's EBITDA (Quarter) stood at -$107.0 million in 2021, then surged by 118.5% to $19.8 million in 2022, then surged by 145.96% to $48.7 million in 2023, then tumbled by 33.68% to $32.3 million in 2024, then crashed by 92.88% to $2.3 million in 2025.
  • Its EBITDA stands at $2.3 million for Q3 2025, versus -$8.5 million for Q2 2025 and $21.3 million for Q1 2025.